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The menopausal transition in human females, which is driven by a loss
of cyclic ovarian function, occurs around age 50 and is thought to
underlie the emergence of an array of health problems in aging
women. Although mice do not undergo a true menopause, female
mice exhibit ovarian failure long before death because of chronolog-
ical age and subsequently develop many of the same age-associated
health complications observed in postmenopausal women. Here we
show in mice that inactivation of the proapoptotic Bax gene, which
sustains ovarian lifespan into advanced age, extends fertile potential
and minimizes many age-related health problems, including bone and
muscle loss, excess fat deposition, alopecia, cataracts, deafness, in-
creased anxiety, and selective attention deficit. Further, ovariectomy
studies show that the health benefits gained by aged females from
Bax deficiency reflect a complex interplay between ovary-dependent
and -independent pathways. Importantly, and contrary to popular
belief, prolongation of ovarian function into advanced age by Bax
deficiency did not lead to an increase in tumor incidence. Thus, the
development of methods for postponing ovarian failure at meno-
pause may represent an attractive option for improving the quality of
life in aging females.
aging  apoptosis  menopause  ovary
Although the process of aging has been attributed in part toincreased apoptosis in various tissues (1), animal models
lacking cell death-regulatory genes are rarely subjected to longitu-
dinal aging studies. In females, one of the first organ systems to fail
with age is the reproductive axis, which in humans is a principal
contributing factor to the onset of menopause (2). Ovarian failure,
whether natural (age-related) or induced as a consequence of
pathological insults, is driven by depletion of ovarian follicles, the
hormonally active support structures that house oocytes, through
apoptosis (3). As a consequence, dramatic changes in the endocrine
activity of the female gonads ensue, which are thought to underlie
the emergence of a spectrum of physiological and psychological
health complications in aging females (2). Although it has been
shown that aged female mice transplanted with ovaries of young
donors live longer than nontransplanted control or ovariectomized
females (4), it remains unclear whether postmenopausal health
complications arise as a direct result of ovarian failure or simply
reflect the aging process.
Despite the fact that mice do not undergo a true menopause,
female mice exhaust their follicle pool long before death because of
chronological age (5), similar to that seen in humans (6). Further,
aging female mice exhibit many of the same health complications
associated with postmenopausal life in women (see below). In a
previous study, we reported that oocyte and follicle loss in female
mice lacking the proapoptotic Bax protein is attenuated, leading to
a dramatic prolongation of ovarian function into very advanced age
(7). To better understand the consequences of Bax deficiency and
sustained ovarian function on the female body with age, herein we
undertook a 7-yr investigation of the aging process inmutant female
mice derived from a breeding colony originally obtained from the
Korsmeyer laboratory in 1996 (8) and maintained on a C57BL/6
congenic background.
Results
Outwardly, striking differences were noted in aged (22 mo) WT
and mutant [Bax gene knockout (KO)] females (Fig. 1 A and B).
Aged KOmice (n 38) were more active and maintained a leaner
body composition thanWT littermates (n 35; see details below).
In addition, by 2 yr of age, 40% of WT females had experienced
30%hair loss, consistentwithpastobservations (www.informatics.
jax.org). By comparison, age-matched KO females exhibited no
visible alopecia (Fig. 1 A and B). More than half (54%) of the WT
females also developed cataracts by 18 mo of age (29% bilateral,
25% unilateral), whereas3% of age-matched KO females devel-
oped this pathology. In addition, wrinkling of the skin, visible by ear
assessment, was widespread in aged WT but not KO mice (Fig. 1
A andB).We also observed that approximately one-third (13 of 38)
of the KO mice exhibited rectal prolapse with age, which was not
seen in WT mice. In light of past findings linking Helicobacter to
rectal prolapse (9, 10), we tested our colony and discovered that our
mice were infected with this microorganism. After generation of a
Helicobacter-free colony, rectal prolapse was no longer observed.
Reproductive performance also markedly differed among geno-
types. Initially, we noted that young adult KO females frequently
failed to produce litters when pairedwith adultWTmales of proven
fertility, but their breeding performance actually improved with
age. During a 3-mo mating trial initiated at 2 mo of age, only 25%
(5 of 20) of KO females became pregnant and delivered pups,
comparedwith a pregnancy and delivery rate of 92% (23 of 25) over
the same 3-mo period in aged-matched WT females. In contrast,
during a 3-mo breeding trial initiated at 8 mo of age,90% (22 of
24) of KO females became pregnant and delivered at least twice,
with an average litter size of five pups. By comparison, and as
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expected, fertility decreasedmarkedly in age-matchedWT females,
such that only 40% (8 of 20) became pregnant, and none of them
deliveredmore thanonce (average litter size of five pups) during the
3-mo mating trial. Female fertility is known to decline with ad-
vancing age in many species, including mice and humans (11), and
this has been partly attributed to increased aneuploidy in oocytes
(12). Preliminary studies showed that the incidence of aneuploidy
in oocytes of WT females increased from 1.4 to 4.5% between 1
(n  72 oocytes) and 8 (n  67 oocytes) mo of age, although this
difference was not statistically different (P  0.05) by 2 analysis.
Further, the incidence of aneuploidy in oocytes of KO females
remained relatively constant between 1 (3.7%, n 54 oocytes) and
8 mo (3.1%, n  32 oocytes) of age, and thus the observed
genotype-dependent differences in reproductive capacity could not
be attributed to differences in aneuploidy.
Nevertheless, KO females maintain ovarian function into very
advanced age and thus do not undergo the murine equivalent of
menopause (7). Even though aged KO females fail to become
pregnant when housed with adult WT males of proven fertility,
aged KO females ovulate mature (metaphase-II) oocytes in re-
sponse to exogenous gonadotropin stimulation, which retain the
capacity for fertilization and embryonic development in vitro (7). In
evaluating the endocrine status of these animals, we observed that
serum levels of follicle-stimulating hormone (FSH) were signifi-
cantly higher in aging (15–20 mo) or aged (21–30 mo) WT vs. KO
females (Fig. 1C), consistent with a maintenance of ovarian func-
tion and hence a negative feedback suppression of FSH release, in
KO animals with age. In contrast, serum estradiol levels did not
differ in aging or aged WT vs. KO mice [supporting information
(SI) Fig. 5], probably because of marked genotype-dependent
differences in the deposition of adipose tissue (discussed below),
which becomes a principal site of estrogen biosynthesis in aging
females (13). To then directly test whether oocytes of aged KO
females can produce viable offspring, we grafted ovarian tissue
from aged (24–32mo) KO females into hemiovariectomized young
adult WT females and housed these animals with heterozygous
adult males.With this type of mating scheme, birth of homozygous-
null offspring would occur only if the oocytes originated from the
grafted KO ovarian tissue (see SI Text for additional details). Three
WT surrogate females produced viable KO offspring (four females
and one male, one of which was derived from an oocyte in grafted
ovarian tissue of a 32-mo-old donor; SI Fig. 6), and all of these
animals developed normally without overt evidence of abnormal-
ities or health complications through to the time of euthanasia at 12
mo of age (data not shown).
Along with the loss of fertility, one of the most widely accepted
consequences of ovarian failure at menopause is osteoporosis (14),
a multifactorial age-related disease characterized by decreased
bone mineral density (BMD) and deterioration of the microarchi-
tecture of trabecular bone (15). Evaluation of bone quality in WT
and KO female mice in young, mid-, and late-adult life (2–3, 7–8,
and 20–22 mo of age, respectively) revealed no genotype-
dependent differences in young adult animals. However, whole-
animal BMD, bone mineral content, and bone area were signifi-
Fig. 2. Changes in body composition with age. (A) KO females (open circles)
exhibit higher whole-animal BMD than WT mice (filled circles) at 20–22 mo of
age. (B and C) Separate analysis of cortical (femoral; B) and trabecular (ver-
tebral;C) bone shows that aged KO females have increased BMD in both types
of bone. (D–F) Although total body weight is unaffected by genotype (D), KO
females exhibit a significant decline in fat mass with age (E) while maintaining
a significantly higher total lean mass (F). Data are the mean SEM with 9–14
mice per group (*, P  0.05 vs. corresponding WT value).
Fig. 1. Initial comparisons of aged WT and Bax-deficient female mice.
Representative outward appearance of WT (A) andBax-null (B) female mice at
24 mo of age. (C) Serum FSH levels in aging (15–20 mo) or aged (21–30 mo) WT
(/) and KO (/) females or in 7-mo-old WT and KO females 4 mo after
ovex. The number of mice analyzed per group is provided in parentheses
above each bar (*, P  0.05 vs. respective WT group).
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cantly elevated in KO females compared with WT controls in late
adult life (Fig. 2A; SI Fig. 7). Further studies revealed that,
compared withWT females, KO females exhibited increased BMD
in both cortical (femoral) and trabecular (vertebral) bones (Fig. 2
B and C). Analysis of cortical bone using the three-point bending
test demonstrated that aged KO females exhibited a 42% increase
in failure strength, a 56% increase in failure strain, and a 148%
increase in modulus of toughness vs. age-matched WT females
(Table 1). Trabecular bone of aged KOmice was also more ductile
than that of WT females, exhibiting a 69% increase in failure strain
and a 117% increase inmodulus of toughness (Table 1). In addition,
microcomputed tomography revealed a 59% increase in trabecular
bone volume and 41% more bone trabeculae in aged KO mice,
resulting in 35% less trabecular separation in aged KO females
(Table 1).
To determine whether these effects were due to the presence of
functional ovaries or to an ovary-independent action of Bax defi-
ciency on bone, we examined 7-mo-old femalemice that underwent
bilateral ovariectomy (ovex) after reaching their growth plateau at
3mo of age.Ovex decreasedwhole-body BMD in bothWTandKO
females to a similar degree (Fig. 3A). Both groups of mice also
showed similar decreases in cortical and trabecular BMD vs. the
respective ovary-intact controls (Fig. 3 B and C). However, verte-
bral compression studies indicated that only KO females exhibited
a significant decrease in failure strength after ovex (Fig. 3D),
eliminating the differences in failure strength because of genotype
observed in ovary-intactmice at 7moof age.Nonetheless, bothWT
and KO females showed striking alterations in the structural
properties of trabecular bone after ovex (Fig. 3E). These findings
collectively indicate that the beneficial effects of Bax deficiency on
bone quality arise from a complex interplay between an ovary-
independent effect of the loss of Bax gene function, most likely in
bone, and a prominent indirect effect involving sustained ovarian
function in the mutant animals. Further, although body weight did
not differ among the genotypes (Fig. 2D), other aspects of body
compositionwere affected byBax deficiencywith age, with themost
notable being a dramatic decrease in fat deposition (Fig. 2E) along
with an increase and maintenance of lean body mass (Fig. 2F). In
addition, ovex-induced increases in fatmass with agewere observed
only in WT females (SI Fig. 8), suggesting that Bax deficiency has
a direct (ovary-independent) effect on adipose deposition in
females.
In a final series of experiments, we explored various aspects of
behavior, learning, and memory in WT and KO females, because
cognitive decline is also frequently associated with aging (2). First,
mice were monitored in the open field test, which is a classical
behavioral task for assessing anxiety and exploratory activity.
Consistent with past studies (16), WT female mice displayed a
pronounced age-related increase in anxious behavior, reflected by
more frequent risk assessment and increased time spent self-
grooming. These behavioral changes were not observed in KO
females (Table 2). Moreover, at 15–17 mo of age, KOmice showed
more active behavior than WT females, spending more time in the
brightly lit central area of the open field and less time in one place,
and engaging in more rearing activity (Table 2).
To next assess learning and memory capacity, WT and KO
females were trained in a fear-conditioning test comprising two
components, cued and contextual. Both components depend on
the amygdala; however, contextual fear conditioning also in-
volves the hippocampus (17). Animals were trained to associate
a foot-shock with either a training context (contextual fear
conditioning) or a tone (cued fear conditioning), which then
triggers a conditional fear response resulting in increased freez-
ing. In the contextual fear memory test, aged (15–17 mo) KO
Table 1. Comparison of mean values ( SEM) for mechanical and structural parameters of
bones between WT (/, n  12) and KO (/, n  9) female mice at 20–22 mo of age
Analysis Parameter
Genotype
/ /
Three-point bending (cortical bone) Failure strength, MPa 124  11 176  20*
Failure strain, % 3.8  0.6 5.9  0.9
Toughness, mJ/mm3 2.9  0.7 7.1  1.5*
Vertebral compression (trabecular bone) Failure strength, MPa 5.7  0.6 6.9  1.0
Failure strain, % 9.7  1.3 16.4  2.5*
Toughness, mJ/mm3 0.33  0.06 0.72  0.15*
Microcomputed tomography (trabecular bone) Volume, % 12.2  0.6 19.5  1.7*
Thickness, m 24.5  1.2 27.4  2.1
Trabecular number, per mm 5.1  0.3 7.2  0.4*
Trabecular separation, m 179  14 116  8*
*, P  0.05 vs. corresponding WT value.
Fig. 3. Impact of the loss of ovarian function on body composition. (A–C)
Ovex reduces whole mouse (A) and cortical (B), but not trabecular (C), BMD
compared with age-matched ovary-intact controls irrespective of genotype
(WT,/; KO,/). (D and E) Although ovex reduces compressive strength of
trabecular bone only in KO females (D), trabecular bone structure is negatively
affected by ovex in both genotypes (E). Data inA–D are the mean SEM with
7–10 mice per group (*, P  0.05 vs. corresponding ovary-intact value),
whereas E depicts representative tomographic scans.
Perez et al. PNAS  March 20, 2007  vol. 104  no. 12  5231
PH
YS
IO
LO
G
Y
females displayed significantly less freezing when compared with
age-matchedWT animals (Fig. 4A), whereas no differences were
observed in the cued memory test (Fig. 4B). Because pain
sensitivity and motor ability were similar in WT and KO females
(SI Fig. 9), the contextual memory deficit detected in aged KO
females most likely reflects hippocampal disorganization and
dysfunction because of excess neurons that fail to be eliminated
by apoptosis in Bax-deficient mice (18).
To further investigate cognitive function, latent inhibition (LI)
and prepulse inhibition (PPI) tests were used. LI is the degree to
which preexposure to a conditioned stimulus (CS) decreases the
meaning of that stimulus when it is later paired with an uncondi-
tioned stimulus (US) and thus reflects the animal’s ability to ignore
irrelevant stimuli. Suppression ratios in aged animals not preex-
posed (NPE) to a CS were similar; however, only aged KO females
developed LI after CS preexposure (Fig. 4C), indicating an im-
proved selective attention over their age-matched WT female
siblings. The PPI test involves attenuation of the acoustic startle
response (ASR) by a weak stimulus (prepulse) executed a short
time before the startle stimulus. Although no significant difference
in ASR to a 120-dB startle stimulus was observed between groups
in young adult life (2–3 mo), the age-related decline in ASR
observed in WT mice was significantly attenuated in KO females
(Fig. 4D). Further, when examining the percent PPI as a function
of prepulse intensity, KOmicemaintained a stable level of PPI with
age compared with the significant age-related decline in PPI noted
inWT females (Fig. 4E). Because PPI depends on hearing (19), and
aging C57BL/6 mice are prone to high-frequency hearing loss
(www.informatics.jax.org), we next applied a wider range of startle
intensities to aged WT and KO females. With the exception of the
two lowest intensities, the ASR was significantly higher in KO vs.
WT females at all other intensities (Fig. 4F). Thus, themaintenance
of PPI in KO females with age likely reflects a reduction in
age-related hearing loss. This conclusion agrees with the known
effect of Bax deficiency on eliminating death of trigeminal sensory
ganglion neurons (18), which project to the cochlea and are
associated with hearing function (20).
Discussion
This work has uncovered several aspects of the aging process in
female mammals not previously known or fully appreciated. For
example, although much has been made of the negative correlation
between maternal age and oocyte quality, oocytes within ovaries
whose function is sustained into very old age by Bax deficiency
remain fully competent to be fertilized and to produce normal
viable offspring if a suitable, i.e., young, endocrine environment is
provided. Such findings agree well with very recent data from
studies of themale germ line, which indicate that dysfunction of the
gonadalmicroenvironment rather than the germ cells per se is a key
aspect of age-related spermatogenic failure (21). The data pre-
sented also provide insight into the importance of both chronolog-
ical age and loss of ovarian function to the deterioration of cortical
Fig. 4. Bax deficiency affects age-related changes in behavior, cognitive func-
tion,andsensoryperception. (AandB)Aged(15–17mo)KO(/) femalesexhibit
a deficit (lower freezing values) in contextual (A) but not cued (B) fear memory
when compared with age-matched WT (/) animals (*, P  0.001 vs. corre-
sponding WT value). (C) Suppression ratios are comparable among genotypes in
aged animals not preexposed to a CS; however, after preexposure to a CS, LI was
present in aged KO but not WT females (*, P 0.01 vs. respective NPE value). (D)
In response to 120 dB, aged WT females exhibit a markedly decreased ASR
compared with young adult (2–3 mo) WT mice (*, P  0.001), whereas no
significant change in ASR is detected in KO females with age. (E) In young adult
WT and KO females, the percent PPI as a function of prepulse intensity is
comparable at all three prepulses; however, aged KO mice exhibit a maintenance
of PPI compared with their aged WT littermates (*,P0.05 vs. corresponding WT
response). (F) The ASR to a wide range of startle intensities in aged WT (filled
circles)andKO(opencircles) femalemice (*,P0.05vs. correspondingWTvalue).
Data are the mean SEM with 9–17 mice per group.
Table 2. Comparison of mean values ( SEM, n  9–17 mice per group) for behavioral
observations in the open field test between WT (/) and KO (/) female mice
Parameter
Two to three mo of age
Fifteen to seventeen mo
of age
/ / / /
Time spent on the periphery, s 132.1  23.2 146.3  12.8 126.0  15.3 133.9  11.7
Time spent in the center, s 22.5  5.7 36.6  10.2 20.4  4.7 52.7  6.8*†
Risk assessment 2.0  0.4 3.0  1.2 5.1  0.8† 2.9  0.9*
Time spent self-grooming, s 3.9  0.07 4.6  0.7 13.5  4.9† 4.8  0.7
Time spent freezing, s 3.4  0.9 3.1  0.7 3.2  0.6 1.2  0.6†‡
Horizontal activity 592.5  103.0 750.8  82.0 612.7  50.6 697.5  55.3
Vertical activity 49.4  13.0 36.6  10.2 38.7  6.4 63.5  9.8‡
*, P  0.01 vs. corresponding age-matched WT value.
†, P  0.05 within each genotype comparing young adult (2–3 mo) and aged (15–17 mo) female mice.
‡, P  0.05 vs. corresponding age-matched WT value.
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and trabecular bone in aging females. Similarly, although increased
adipose deposition results from the absence of functional ovaries,
ovary-independent pathways influenced directly by Bax also con-
tribute to fat accumulation with age. In addition, striking improve-
ments in several behavioral domains that relate to cognition,
anxiety, and sensory perception were observed in aged Bax-
deficient females.
Althoughpostmenopausal health problemshave beenmost often
attributed to a loss of estrogen production, the reproductive hor-
mone assessments indicate this may not be the case, at least in aging
femalemice.Along these lines, a very recent study has reported that
age-related bone loss in females is actually because of the elevated
secretion of FSH, and a direct catabolic effect of FSH on bone,
rather than a decline in ovarian estrogen production (22). Further,
the actions of FSH appear to require TNF- as amediator, possibly
by its ability to expand the number of osteoclast precursors in bone
marrow (23). Our data fully agree with this in that the genotype-
dependent differences in BMD with age were correlated with
differences in the circulating levels of FSH and not estradiol. The
estradiol levels detected in the blood of aged WT females likely
reflect elevated peripheral production of this steroid from the
increased adipose deposition noted in WT, but not KO, females.
Indeed, a shift from ovarian to peripheral estrogen production has
been documented in postmenopausal women, accompanied by
increased expression and activity of aromatase in fat tissue (13, 24,
25). Thus, our data add support to the emerging concept that
postmenopausal increases in circulating FSH, independent of
changes in the levels or site of estrogen production, are responsible
for age-related bone loss in females (26). Finally, it should be noted
that the low level of FSH secretion detected in agedKOanimalswas
not because of a defect at the level of the pituitary caused by Bax
deficiency, since a comparable hypersecretion of FSHwas detected
in WT and KO females following ovex (Fig. 1C).
Somewhat surprisingly, despite the apparently increased quality
of life of aging females lacking Bax, no significant differences in
overall lifespan were found between KO (22.3  5.5 mo, n  30)
and WT (26.7  4.8 mo, n  32) animals (P  0.05). In fact, the
absence of lifespan extension in KO females, which remain ex-
tremely lean with age, contrasts a past study of mice with a
fat-specific insulin receptor KO that concluded, ‘‘leanness, not food
restriction, is a key contributor to extended longevity’’ in caloric-
restricted mice (27). Of final note, and in full agreement with past
work from others (28), we did not observe an increase in tumor
incidence in aged KO females (data not shown; see SI Text).
Although these findings contrast inferences from clinical studies
that efforts to sustain ovarian function in aging females might
predispose them to cancer, particularly in steroid-sensitive tissues
such as the breast (29), these data actually align well with very
recent observations from the Women’s Health Initiative indicating
that estrogen supplementation in women aftermenopause does not
increase, but may actually decrease, breast cancer risk (30). There-
fore, development of methods for postponing ovarian failure at
menopause may represent an attractive option for improving the
quality of life in aging females.
Materials and Methods
Animals. WT and KO female mice were generated by mating of
Bax-heterozygous animals, as detailed (8). All animal procedures
were approved by the respective institutional animal care and use
committees of Massachusetts General Hospital, Michigan State
University, and Mount Sinai Hospital.
Aneuploidy Analysis.Chromosomepreparations from single oocytes
were made by using the air-dried technique of Tarkowski (31) and
then analyzed as detailed (ref. 32; see also SI Text for additional
details).
Ovarian Transplantation andMating Trials.As described (33), ovaries
were aseptically collected from aged (24–32 mo) KO females,
placed in Petri dishes containing 2ml ofmodified human tubal fluid
(Irvine Scientific, Santa Ana, CA), and dissected free from the fat
pad and bursa. WT female mice (from the same colony) at 21–23
d of age were anesthetized, and the surgical field was prepared for
aseptic surgery.Oneovarywas removed through a single dorsal skin
incision across the lumbar area, and a transplant consisting of
one-half of an ovary from an agedKOdonor was then placed inside
the empty ovarian bursa. The incision was closed with surgical clips,
and 2 wk after surgery, all recipients were placed in mating trials
with adult Bax-heterozygous males of proven fertility.
Body Composition. WT and KO female mice were randomly as-
signed to three age groups for analysis: 2–3, 7–8, or 20–22 mo of
age. Additional WT and KO mice were subjected to ovex at 3 mo
of age and euthanized with age-matched ovary-intact females at 7
mo of age for comparative studies. Dual-energy x-ray absorptiom-
etry (DEXA), using a PIXImus mouse densitometer (GE Medical
Systems Lunar, Madison,WI), was performed to determine whole-
mouse BMD, bone mineral content, total bone area, total fat mass,
and total lean mass (34). Additional DEXA scans were performed
on the excised lumbar vertebrae and femora to determine BMD of
specific bone regions. Evaluation of the mechanical properties of
cortical bonewas based on subjecting excised right femora to failure
tests using the three-point bending procedure (35). Fourth or fifth
lumbar vertebraewere subjected to failure tests or analyzed by using
microcomputed tomography (eXplore Locus SP Specimen Scanner
andMicroViewCT visualization software; GEMedical Systems) to
evaluate trabecular bone properties (architecture, volume, thick-
ness, density, and separation).
Hormone Assessments. Serum samples collected from WT and KO
female mice between 15–20 and 21–30 mo of age were analyzed by
highly specific radioimmunoassays for FSH and estradiol through
the facilities of National Hormone and Pituitary Program directed
by A. F. Parlow (Harbor–University of California Los Angeles
Medical Center, Torrance, CA).
Open-Field Observations (Behavioral Studies). Each mouse was indi-
vidually placed in the center of a brightly lit open field equipped
with infrared sensors to automatically record horizontal and vertical
movements (Ugo Basile, Malvern, PA). The following parameters
were recorded over a 5-min interval: number of interruptions of the
horizontal and vertical sensors, duration of passive behavioral
episodes (sitting in one place without any visible movements or
‘‘freezing’’), duration of self-grooming, number of risk assessments
(behavior involving themouse stretching its body from corners/wall
toward the center), duration of exploratory activity, and duration of
active walking in the center area (5 cm from the walls) vs. activity
close to the walls (within 5 cm of the walls).
Contextual and Cued Fear Conditioning. The fear-conditioning ex-
periment was performed in sound-attenuated chamber (Med As-
sociates, St. Albans, VT) equipped with a computer-controlled fear
conditioning system (Actimetrics, Wilmette, IL). The conditioning
procedure consisted of placing each mouse inside the chamber and
allowing it 3 min of baseline exploratory activity. A 3.6-kHz
pulsated tone (75 dB), which served as a CS, was then presented for
20 s, followed by a foot-shock (2 s, 0.6 mA), which served as a US.
Two more CS–US pairings were presented with 2-min intertrial
intervals. The mouse was removed from the chamber 30 s after the
last CS–US pairing and returned to its home cage. The distance
traveled in pixels between successive frames shot at three frames
per second during the foot-shock interval was used as a measure-
ment of the unconditional response of each mouse. Using known
reference marks in the box, these values were converted into real
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distance (centimeters) and then into velocity (centimeters per
second).
To evaluate contextual fear memory, the mouse was placed back
into the training context 24 h after training, and freezing behavior
was measured for 5 min in the absence of tone or shock. Fear
memory to the tone was evaluated 24 h after the context test. The
tone test consisted of two phases. In the first phase (pre-CS), the
mouse was placed in a novel context (novel odor, lighting, cage
floor, and visual cues), and freezing behavior was measured for 3
min in the absence of the tone. In the second phase (CS), the tone
was presented, and freezing behavior was measured for another 3
min. Freezing behavior, defined as the complete absence of any
movement except for respiration and heartbeat (36), was measured
during the context and cued conditioning tests at 0.25-s intervals
by using FreezeFrame automated fear conditioning software
(Actimetrics).
LI. Before beginning the LI experiments, mice were weighed, and
water was removed from the cages for 24 h. During the first 5 d,
water-deprived mice were trained to drink in the sound-attenuated
chamber for 15 min/d. The mice in each age group were further
separated into two groups:NPEandpreexposed (PE). ThePEmice
received 40 white-noise tones as CS (85 dB, 10-s duration, 60-s
interstimulus interval), whereas the NPE group received no stimuli
during an equivalent period in the chamber. The next day, all mice
received two CS/foot-shock (1 s, 0.37 mA) pairings given 5 min
apart, with the shock given immediately after the CS. On the test
day, the CS was presented after mice had completed 75 licks, and
it lasted until lick 101. During the test, the following observations
were recorded: time to first lick, time to complete licks 50–75
(before CS onset, period A), and time to complete licks 76–101
(after CS onset, period B). The degree of lick suppression was
expressed as a suppression ratio, A/(A  B). A lower suppression
ratio indicates a stronger suppression of drinking, and LI is defined
as a significantly higher suppression ratio score in the PE compared
with the NPEmice. There were eight experimental groups in a 2
2  2 design with main factors of PE (0 or 40), genotype (WT or
KO), and age (2–3 or 15–17 mo).
PPI. For PPI, five types of trials were performed in the sound-
attenuated chamber: startle-pulse-alone trials (sp), which consisted
of a single tone burst (10 kHz, 120 dB, 40 ms); three prepulse-plus-
startle trials (pp-sp) that preceded the startle pulse by 100 ms and
consisted of prepulses (10 kHz, 20 ms) at 69, 73, or 81 dB (pp69sp,
pp73sp, and pp81sp); and no-stimulus trials (ns), which consisted of
background noise only (65 dB). Sessions were structured as follows:
(i) a 15-min acclimation to background noise levels; (ii) five sp trials;
(iii) 10 blocks each containing all five trials (sp, pp69sp, pp73sp,
pp81sp, and ns) in pseudorandom order; and (iv) five sp trials.
Intertrial intervals were set between 12 and 30 s. The startle level
was quantified by force intensity through a floor-plate sensor. For
eachmouse, the PPI at each prepulse was expressed as a percentage
of the amplitude of the mean startle response alone for that mouse
and the startle response to pulse alone.
ASR. Each mouse was placed in the sound-attenuated chamber and
allowed to acclimate for 5 min, after which 80 startle stimuli of
varying intensities were presented, with a duration of 50 ms and a
variable interstimulus interval of 20–30 s. The following stimulus
intensities were applied: 85, 90, 95, 100, 105, 110, 115, and 120 dB.
Ten trials were presented in three blocks of eight stimuli and in
pseudorandom order within a block.
Longevity Studies. WT and KO female mice were housed and
maintained under identical conditions without any experimental
manipulation, and lifespan was recorded. Animals that died pre-
maturely before reaching at least one-half of normal lifespan (i.e.,
12 mo of age) (WT, n  3; KO, n  8) were excluded from the
analyses.
Data Analysis. All experiments were independently replicated with
at least four mice per group (see text and legends for specific
numbers in each experiment), and the data shown in text, graph, or
table form represent the mean  SEM of combined results.
Depending on the experiment, data analysis was performed by
one-way, two-way, or multiple ANOVA, followed by t tests, least-
significant difference post hoc comparisons, or Tukey least signif-
icant difference post hoc tests (see SI Text for additional details).
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